Spend $99, get free U.S. shipping*

Tariff now required on U.S. shipments. Learn more »

Tel: 1-866-456-3768 Fax: 1-866-544-8993

Home / Online Pharmacy / Mounjaro

For visual reference only; actual product may vary

US Name:

Mounjaro
Alternative Names:

Mounjaro, Zepbound
Active Ingredients:

Tirzepatide
Brand Manufacturer:

Lilly
Manufacturer Location:
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

Mounjaro ^*

For visual reference only; actual product may vary

Prescription Required

All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Mounjaro is prescribed for glycemic control of adult patients with type 2 diabetes. Each order comes with 4 vials of medication and syringes for injection, or 1 Kwikpen, for a total of 4 weeks use. **Special Order** Please order early as it can take up to 10 days to receive stock.

The cost for 4 vials (28 days supply) is $750

The cost for 1 Kwikpen (28 days supply) varies based on the dose required

Mounjaro® and Zepbound® and their delivery device bases are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Place your order

Mounjaro Kwikpen Brand	15mg 1 Pen (4 doses)	- Mounjaro – Brand, Mounjaro Kwikpen, 15mg, 1, Pen (4 doses), 888888, Eli Lilly, 2682 + 0	Our price: $1,025.00
Mounjaro Kwikpen Brand	12.5mg 1 Pen (4 doses)	- Mounjaro – Brand, Mounjaro Kwikpen, 12.5mg, 1, Pen (4 doses), 888888, Eli Lilly, 2572 + 0	Our price: $1,025.00
Mounjaro Kwikpen Brand	10mg 1 Pen (4 doses)	- Mounjaro – Brand, Mounjaro Kwikpen, 10mg, 1, Pen (4 doses), 888888, Eli Lilly, 2571 + 0	Our price: $800.00
Mounjaro Kwikpen Brand	7.5mg 1 Pen (4 doses)	- Mounjaro – Brand, Mounjaro Kwikpen, 7.5mg, 1, Pen (4 doses), 888888, Eli Lilly, 2570 + 0	Our price: $800.00
Mounjaro Kwikpen Brand	5mg 1 Pen (4 doses)	- Mounjaro – Brand, Mounjaro Kwikpen, 5mg, 1, Pen (4 doses), 888888, Eli Lilly, 2569 + 0	Our price: $700.00
Mounjaro Kwikpen Brand	2.5mg 1 Pen (4 doses)	- Mounjaro – Brand, Mounjaro Kwikpen, 2.5mg, 1, Pen (4 doses), 888888, Eli Lilly, 2568 + 0	Our price: $700.00
Mounjaro Brand	2.5mg 4 Vials	- Mounjaro – Brand, Mounjaro, 2.5mg, 4, Vials, 888888, Eli Lilly, 2182 + 0	Our price: $750.00

Saul Recommends

Healthy Weight Pack

30 Pouches
1 Pouch a Day

–

Our price:
$81.60

*Please note all prices are in US dollars

Description
Side Effects
Indications
FAQ
Video

Mounjaro (generic name: tirzepatide) is an injectable prescription medicine that is used to treat adults with type 2 diabetes. It is prescribed along with diet and exercise to improve control of blood sugar levels. Mounjaro is widely used thanks to its efficacy and safety as a single therapy or with other diabetes medicines< Tirzepatide (GIP/GLP-1 RA) is a single molecule combining glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1RA). It activates the secretion of GIP and GLP-1 receptors from the intestines on ingestion of glucose or nutrients, which in turn stimulates insulin secretion from pancreatic β cells. It also is active in regions of the brain that regulate food intake. Tirzepatide slows down the emptying of the stomach after eating, leaving people feeling full for longer and suppressing appetite. While there is no cure for diabetes, it was found in studies of Mounjaro that after 52 weeks, when administered both with or without other diabetes medications, 75% to 90% of patients with an average starting HbA1C of 7.9% to 8.6% reached an HbA1C of less than 7%. Mounjaro is also effective to induce weight reduction and its sister drug Zepbound has been approved by the FDA for weight loss since November 2023. In studies, weight loss in adults ranged from 12 lb (5 kg) to 25 lb (10 kg). The results in trials where candidates received tirzepatide surpassed the weight lost in trials of other GLP-1 agonists. Mounjaro can only be prescribed off-label for patients classified as overweight (Body Mass Index between 27 and 30) with at least one weight-related comorbid condition, such as dyslipidemia, hypertension, obstructive sleep apnea, or cardiovascular disease) or obese (BMI 30 or higher). Mounjaro is not for use in people with type 1 diabetes.

Dosage

Follow the prescribing doctor’s dosage instructions which are printed on the label of the box. Check with a doctor or pharmacist if there are any doubts regarding the proper dosage and treatment regimen. People prescribed Mounjaro will often begin on a low dose and gradually increase based on tolerance and healthcare guidance. Mounjaro Kwikpen contain 4 doses. It should be administered once each week on the same day of the week and at approximately the same time of day. It must injected in rotation in either the abdomen, thigh, or upper arm by choosing a different site each week. If a dose is missed, it can be made up for within three days, but beyond that, the dose must be skipped and the routine dose taken on the due date. Do not take two doses of Mounjaro within 72 hours of each other and if it is necessary to change the day, make sure there are at least 72 hours in between doses. If taking insulin and Mounjaro simultaneously, do not inject them close together in the same area. Carefully read the information and follow instructions on the manufacturer Eli Lilly and Company’s Product Insert leaflet that comes with the medication to ensure safe usage. Watch a step-by-step video on how to use Mounjaro. We cannot be held liable for any harm caused by incorrect usage.

Storage

Store Mounjaro in the refrigerator (2–8°C/36-48°F). Do not freeze and if one has been frozen, do not use it. Store the pens and vials in their original packaging in order to protect them from light.> Mounjaro can be kept unrefrigerated, but not above 30ºC (86°F), for up to 21 days. If the medicine has been left out of the refrigerator for more than 21 days, it must be discarded, even if the expiry date has not yet been reached.

This text is for informational purposes only. Please consult a doctor or pharmacist before using any medication.

The information leaflet that comes with the medication includes full information about the possible side effects. Be sure to read and understand these, and if there are any questions, discuss these with a healthcare provider or pharmacist before starting treatment.

Caution:

If a sudden allergic reaction (anaphylaxis) occurs after taking Mounjaro, with symptoms like swelling of the face, tongue, or throat making it difficult to breathe or swallow, or there is wheezing, hives, rash, blistering, or peeling of the skin, call a doctor or 911 right away, or go to an emergency room immediately.

For people who have kidney problems, side effects like diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important to drink fluids to help reduce any chance of dehydration.

Most people who use Mounjarodo not experience any adverse side effects. Doctors prescribe this medication because they assess the benefits of such treatment outweigh any likely unwanted effects.

Some of the side effects that have been reported are:

Nausea
Diarrhea
Decreased appetite
Vomiting
Constipation
Indigestion
Stomach pain.

If these persist or worsen, consult with a healthcare provider.

Most nausea, vomiting, and diarrhea events occurred while the dose of Mounjaro was being increased and this decreased over time.

Please note that not all possible side effects can be listed. If any of these or other unexpected side effects are experienced, seek medical attention promptly.

Rare side effects requiring immediate attention

Gallbladder problems have been reported by some people using Mounjaro. Tell a healthcare provider right away if symptoms of gallbladder problems appear, which may include pain in the upper abdomen, fever, yellowing of skin or eyes (jaundice), and clay-colored stools.

Mounjaro may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If any of these symptoms occur, consult a healthcare provider.

Do not use Mounjaro if you or any member of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.

Mounjaro may cause serious side effects, including:

Inflammation of the pancreas (pancreatitis). Stop using Mounjaro and call a healthcare provider right away if there is severe pain in the stomach area (abdomen) that will not go away, with or without vomiting. Pain may be felt from the abdomen to the back.
Low blood sugar (hypoglycemia). The risk for getting low blood sugar may be higher if Mounjaro is used along with with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
Changes in vision. Tell a healthcare provider if there are changes in vision during treatment with Mounjaro.

Mounjaro (tirzepatide, combining GIP and GLP-1 receptor agonists) treats adults with type 2 diabetes. It has not yet been approved for children under the age of 16.

The drug can lower blood sugar levels, but is not a cure for diabetes. Do not stop taking Mounjaro without consulting with a doctor.

Zepbound can also be prescribed for patients who are overweight with ancilliary problems such as dyslipidemia, hypertension, obstructive sleep apnea, or cardiovascular disease, and for people who are obese (BMI higher than 30).

You can take the dose within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take the next dose on the regularly scheduled day. Do not take 2 doses of Mounjaro within 3 days of each other.
The risk of getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Symptoms of hypoglycemia may include dizziness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes. Consult immediately with a healthcare provider or go to an emergency care center.
Tirzepatide can works in several ways to promote weight loss. GIP/GLP-1RA molecules slow down the emptying of the stomach and inhibit hunger, which can suppress appetite. People being treated feel satiated for longer after meals and therefore eat less. After extensive peer reviewed clinical trials in which tirzepatide compared to other options, it has been approved by the FDA as a weight loss drug and is marketed under the brand name Zepbound.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Categories

Resources